-
Ovarian cancer patients relapsing within 6 months of their primary therapy represent among the most challenging patients to treat. Generally, in this setting, most patients have only been exposed to one or two agents, yet they are phenotypically resistant to most chemotherapeutics, making drug discovery of paramount importance.
-
Richards and colleagues representing the Canadian Multicentre Osteoporosis Study Research Group reported the effect of daily selective serotonin reuptake inhibitors (SSRIs) use in a prospective cohort study in 7 regional centers of 5008 adults over the age of 50.
-
-
High-Dose Statin Therapy, Value for Older Adults; Simvastatin, Best for Parkinson's Disease; Polyethylene Glycol for Chronic Constipation; FDA Actions
-
Glass and colleagues from the Kaiser Permanente Northwest Center for Health Research compared breast cancer incidence rates with use of screening mammography and postmenopausal hormone therapy prescriptions between 1980 and 2006.
-
-
Estrogen for Younger Postmenopausal Women; Warfarin Better for Atrial Fibrillation Patients; FDA Actions
-
This research team looked at the sensitivity measurements to pressure at both the vulva and thumb as they randomly assigned the order of tests. This was repeated a week later on the contralateral side. Among 13 women with vulvodynia and 20 control patients, there was a strong correlation between the two visits, and there was no order effect noted.
-
Aside from advanced maternal age, two of the most common reasons for referral for a genetic sonogram are fetal choroid plexus cysts (CPCs) and echogenic intracardiac foci (EIFs).
-
The Women's Health Initiative (WHI) Coronary-Artery Calcium Study (WHI-CACS) was an ancillary study of estrogen-only participants in 28 of the 40 WHI centers.